Cyclophosphamide Plus Cisplatin Versus Cyclophosphomide, Doxorubicin, and Cisplatin Chemotherapy of Ovarian-carcinoma - a Metaanalysis
暂无分享，去创建一个
[1] N. Rawson,et al. Adjuvant chemotherapy in head and neck cancer. , 1990, British Journal of Cancer.
[2] David R. Cox,et al. Regression models and life tables (with discussion , 1972 .
[3] I. Strøyer,et al. A randomized study of cyclophosphamide and cis-platinum with or without doxorubicin in advanced ovarian carcinoma. , 1987, Gynecologic oncology.
[4] R Collins,et al. Avoidance of large biases and large random errors in the assessment of moderate treatment effects: the need for systematic overviews. , 1987, Statistics in medicine.
[5] J. Berek,et al. Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: a Gynecologic Oncology Group Study. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] M. Buyse,et al. Analysis of clinical trial outcomes: some comments on subgroup analyses. , 1989, Controlled clinical trials.
[7] A. Reinberg,et al. Chemotherapy of advanced ovarian cancer with 4'-O-tetrahydropyranyl doxorubicin and cisplatin: a randomized phase II trial with an evaluation of circadian timing and dose-intensity. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] M. Buyse,et al. Adjuvant therapy of colorectal cancer. Why we still don't know. , 1988, JAMA.